Scientists genetically grab PTEN by the tail to curtail cancer
A white paper, How is a Shortage of Primary Care Physicians Affecting the Quality and Cost of Medical Care?, released today by the American College of Physicians (ACP) documents the value of primary care by reviewing 20 years of research. An annotated bibliography based on a literature review of more than 100 studies documents the
Full Post: How is a shortage of primary care physicians affecting the quality and cost of medical care?
When researchers look inside human cancer cells for the whereabouts of an important tumor-suppressor, they often catch the protein playing hooky, lolling around in cellular broth instead of muscling its way out to the cells’ membranes and foiling cancer growth.
This phenomenon of delinquency puzzled scientists for a long time - until a cell biologist in the Johns Hopkins University School of Medicine felt compelled to genetically grab the protein by the tail and then watched as it got back to work at tamping down disease.
“It was curious that when we removed its tail, the protein suddenly was unhindered and moved out to the membrane and became active,” says Meghdad Rahdar, a graduate student in pharmacology.
The discovery, published Dec. 15 online at the Proceedings of the National Academy of Sciences , represents a potential new approach to cancer therapy, according to Peter Devreotes, Ph.D., professor and director of cell biology at Johns Hopkins.
“A long-term goal is to find a drug that does the equivalent of our bit of genetic engineering,” he says.
The flexible tail contains a cluster of four amino acids - the building blocks of proteins - that regulate this tumor suppressor known as PTEN. When chemically modified, these amino acids act to “glue” the tail back to the body of PTEN and prevent the attachment of PTEN to the membrane. By genetically removing PTEN’s tail, or manipulating the cluster of four amino acids so that they cannot be modified, the researchers persuaded PTEN to move to the cell membrane where it goes about its tumor-suppressing business of degrading a molecular signal called PIP3 that causes errant cell growth.
“As far as I know, I haven’t seen anyone activate a tumor suppressor, but we seem to have done it genetically,” Rahdar says.
While genetically engineering cancer cells in the human body is neither practical nor safe, manipulating such unbinding of PTEN with drugs is a viable alternative to guard against cell overgrowth, the hallmark of cancer, the Hopkins scientists say.
In many tumors, PTEN is simply not present. In others, it’s there, but a key enzyme that produces PIP3 is over-activated. The Hopkins team already has shown the first evidence that adding the modified PTEN to cells that lack PTEN not only restores normal enzyme levels but ramps up PTEN activity and quells the cell growth signal.
The research was supported by the National Institutes of Health.
In addition to Rahdar and Devreotes, authors on the paper are Takanari Inoue, Tobias Meyer, Jin Zhang and Francisca Vazquez, all of Johns Hopkins.
CANCER RESEARCH UK scientists have shown how bowel cancer can become aggressive, according to research published in Nature Genetics. The researchers, based in the Cardiff School of Biosciences, Cardiff University and at Cancer Research UK’s Beatson Institute in Glasgow found that a tumour suppressor protein called Pten is critical in stopping tumours from growing in
Full Post: Scientists find a trigger to aggressive bowel cancer
Cancer and cell biology experts at the University of Cincinnati (UC) have identified a new tumor suppressor that may help scientists develop more targeted drug therapies to combat lung cancer. The study, led by Jorge Moscat, PhD, appears in the January 2009 issue of Molecular and Cellular Biology . Proto-oncogenes are genes that play a
Full Post: Discovery of new tumor suppressor for lung cancer
Garbage collectors are important for removing trash; without them waste accumulates and can quickly become a health hazard. Similarly, individual cells that make up such biological organisms as humans also have sophisticated methods for managing waste. For example, cells have developed complex systems for recycling, reusing and disposing of damaged, nonfunctional waste proteins. When such
Full Post: Researchers describe how cells recycle protein waste
Researchers at the University of Southern California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models. Researchers say the upcoming study in the Proceedings of the National Academy of Sciences - now available online - may lead to a novel cancer therapy
Full Post: Discovery of novel approach to suppress prostate cancer progression
Taking a cue from the way drugs like Viagra put the biological brakes on a key enzyme involved in heart failure, scientists at Johns Hopkins have mapped out a key chemical step involved in blocking the enzyme. The Johns Hopkins team reports how the enzyme, phosphodiesterase 5, or PDE5A, slows down the breakdown of another,
Full Post: Scientists map steps to block enzyme phosphodiesterase 5’s action in heart failure